DOTAGA.Glu.(FAPi)2

DOTAGA.Glu.(FAPi)2

• CAS Number: 2882922-68-9
• UNSPSC Description: DOTAGA.Glu.(FAPi)2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging[1].
• Target Antigen: Radionuclide-Drug Conjugates (RDCs)
• Type: Reference compound
• Related Pathways: Antibody-drug Conjugate/ADC Related
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/dotaga-glu-fapi-2.html
• Smiles: O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(OCCCCNC([C@H](CCC(NCCCCOC4=CC5=C(N=CC=C5C(NCC(N6[C@@H](CC(F)(C6)F)C#N)=O)=O)C=C4)=O)NC(CCC(N7CCN(CCN(CCN(CC7)CC(O)=O)CC(O)=O)CC(O)=O)C(O)=O)=O)=O)C=C3)=O
• Molecular Weight: 1432.43
• References & Citations: [1]RÖSCH Frank, et al. TRISLINKER-CONJUGATED DIMERIC LABELLING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM. WO2022258637. 2022 December 15.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported